Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature
- 1 June 2018
- journal article
- review article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 16 (3) , 176-183
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunityCurrent Opinion in Immunology, 2012
- Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III renal cell carcinomaInternational Journal of Clinical Oncology, 2011
- Renal cell carcinoma with an emphasis on drug therapy of advanced disease, part 2American Journal of Health-System Pharmacy, 2009
- Renal cell carcinoma with an emphasis on drug therapy of advanced disease, part 1American Journal of Health-System Pharmacy, 2009
- Randomized Trial of Adjuvant Thalidomide Versus Observation in Patients With Completely Resected High-Risk Renal Cell CarcinomaUrology, 2009
- Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter StudyJournal of Clinical Oncology, 2004
- Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized TrialJournal of Clinical Oncology, 2003
- Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and Bacillus Calmette-Guèrin: Five-year results of a prospective randomized studyCancer, 1996
- Monoclonal antibody G 250 recognizes a determinant present in renal‐cell carcinoma and absent from normal kidneyInternational Journal of Cancer, 1986
- Therapy of spontaneous metastases with an autologous tumor vaccine in a guinea pig modelJournal of Surgical Research, 1981